<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04976439</url>
  </required_header>
  <id_info>
    <org_study_id>MUTASICRC</org_study_id>
    <nct_id>NCT04976439</nct_id>
  </id_info>
  <brief_title>Patogenic Mutation in 5 Genes</brief_title>
  <official_title>Genomic Landscape of APC, KRAS, TP53, PIK3CA, and MLH1 in Colorectal</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Dr Cipto Mangunkusumo General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Dr Cipto Mangunkusumo General Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a pathogenic mutation profile of colorectal patients specifically in 5 genes, i.e.&#xD;
      APC, TP53, PIK3CA, KRAS, and MLH1. Single nucleotide variants identified were synchronized&#xD;
      with patients' characteristics.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">May 1, 2021</start_date>
  <completion_date type="Actual">June 14, 2021</completion_date>
  <primary_completion_date type="Actual">June 10, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Retrospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Description of clinical characteristics</measure>
    <time_frame>January 2017 - June 2021</time_frame>
    <description>Age, gender</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Description of tumor nature</measure>
    <time_frame>January 2017 - June 2021</time_frame>
    <description>grade, stage, lymphovascular invasion, tumor location</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Description of survival</measure>
    <time_frame>January 2017 - June 2021</time_frame>
    <description>Median of life expectancy</description>
  </primary_outcome>
  <number_of_groups>5</number_of_groups>
  <enrollment type="Actual">22</enrollment>
  <condition>Colorectal Cancer</condition>
  <condition>APC Gene Mutation</condition>
  <condition>TP53 Gene Mutation</condition>
  <condition>PIK3CA Gene Mutation</condition>
  <condition>KRAS Mutation-Related Tumors</condition>
  <condition>MLH1 Gene Mutation</condition>
  <arm_group>
    <arm_group_label>Age</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Grade</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Tumor location</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Stage</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Lymphovascular invasion</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>co-occuring mutation</intervention_name>
    <description>APC, TP53, PIK3CA, KRAS APC, TP53, PIK3CA, MLH1 APC, TP53, PIK3CA, KRAS, and MLH1 APC, TP53, PIK3CA</description>
    <arm_group_label>Age</arm_group_label>
    <arm_group_label>Grade</arm_group_label>
    <arm_group_label>Lymphovascular invasion</arm_group_label>
    <arm_group_label>Stage</arm_group_label>
    <arm_group_label>Tumor location</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        This is a descriptive study in patients with colorectal malignancies who underwent surgery&#xD;
        and/or chemoradiation and/or chemotherapy at RSCM, RSKJ, and MRCCC in 2017-2018 whose tumor&#xD;
        tissue specimens were still properly stored in the form of formalin-fixed paraffin-embedded&#xD;
        (FFPE). .&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  FFPE samples fullfilling purity criterion and pass quality control&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  none&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Vania Myralda Giamour Marbun</name>
      <address>
        <city>Jakarta</city>
        <state>ALL</state>
        <zip>12740</zip>
        <country>Indonesia</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Indonesia</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 2, 2021</study_first_submitted>
  <study_first_submitted_qc>July 21, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">July 26, 2021</study_first_posted>
  <last_update_submitted>July 21, 2021</last_update_submitted>
  <last_update_submitted_qc>July 21, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">July 26, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Dr Cipto Mangunkusumo General Hospital</investigator_affiliation>
    <investigator_full_name>Vania Myralda Giamour Marbun</investigator_full_name>
    <investigator_title>Principal Investigator - Staff of Digestive Division - General Surgery Department</investigator_title>
  </responsible_party>
  <keyword>next-generation sequencing</keyword>
  <keyword>colorectal cancer</keyword>
  <keyword>indonesia population</keyword>
  <keyword>co-occurring mutation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

